Picture of Cipher Pharmaceuticals logo

CPH — Cipher Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Cipher Pharmaceuticals Reports Q4 Revenue Of $6.1 Mln

March 18 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO :
    * CIPHER PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR 2020
FINANCIAL RESULTS
    * CIPHER PHARMACEUTICALS INC - QTRLY TOTAL REVENUE INCREASED
3.4%
TO $6.1 MILLION FROM $5.9 MILLION
    * CIPHER PHARMACEUTICALS - QTRLY LOSS FROM CONTINUING
OPERATIONS
WAS $0.1 MILLION, OR LOSS OF $0.00 PER BASIC & DILUTED SHARE

Source text for Eikon:  ID:nCNWfBlVJa 
Further company coverage:  CPH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cipher Pharmaceuticals

See all news